The controversial role of human gut lachnospiraceae

M Vacca, G Celano, FM Calabrese, P Portincasa… - Microorganisms, 2020 - mdpi.com
The complex polymicrobial composition of human gut microbiota plays a key role in health
and disease. Lachnospiraceae belong to the core of gut microbiota, colonizing the intestinal …

Mitochondria and reactive oxygen species in aging and age-related diseases

C Giorgi, S Marchi, ICM Simoes, Z Ren… - International review of …, 2018 - Elsevier
Aging has been linked to several degenerative processes that, through the accumulation of
molecular and cellular damage, can progressively lead to cell dysfunction and organ failure …

DPP4 in diabetes

D Röhrborn, N Wronkowitz, J Eckel - Frontiers in immunology, 2015 - frontiersin.org
Dipeptidyl-peptidase 4 (DPP4) is a glycoprotein of 110 kDa, which is ubiquitously expressed
on the surface of a variety of cells. This exopeptidase selectively cleaves N-terminal …

Metabolic syndrome

SL Samson, AJ Garber - Endocrinology and Metabolism Clinics, 2014 - endo.theclinics.com
A medical syndrome is a clustering of clinical findings that occur together more often than
would be expected by chance. The constellation of components that make up the metabolic …

[HTML][HTML] Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update

GÖ Elpek - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
There have been considerable recent advances towards a better understanding of the
complex cellular and molecular network underlying liver fibrogenesis. Recent data indicate …

Nonalcoholic fatty liver disease (NAFLD). Mitochondria as players and targets of therapies?

A Di Ciaula, S Passarella, H Shanmugam… - International Journal of …, 2021 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and
represents the hepatic expression of several metabolic abnormalities of high epidemiologic …

Hepatic consequences of COVID-19 infection. Lapping or biting?

P Portincasa, M Krawczyk, A Machill, F Lammert… - European journal of …, 2020 - Elsevier
The outbreak of coronavirus disease 2019 (COVID-19) starting last December in China
placed emphasis on liver involvement during infection. This review discusses the underlying …

In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)

G Kanuri, I Bergheim - International journal of molecular sciences, 2013 - mdpi.com
By now, non-alcoholic fatty liver disease (NAFLD) is considered to be among the most
common liver diseases world-wide. NAFLD encompasses a broad spectrum of pathological …

Iron overload in alcoholic liver disease: underlying mechanisms, detrimental effects, and potential therapeutic targets

LX Li, FF Guo, H Liu, T Zeng - Cellular and Molecular Life Sciences, 2022 - Springer
Alcoholic liver disease (ALD) is a global public health challenge due to the high incidence
and lack of effective therapeutics. Evidence from animal studies and ALD patients has …

[HTML][HTML] The fatty acid–bile acid conjugate aramchol reduces liver fat content in patients with nonalcoholic fatty liver disease

R Safadi, FM Konikoff, M Mahamid… - Clinical …, 2014 - Elsevier
Background & Aims We investigated the effects of the fatty acid–bile acid conjugate 3β-
arachidyl-amido, 7α-12α-dihydroxy, 5β-cholan-24-oic acid (Aramchol; Trima Israel …